Don’t miss this opportunity to connect with NIBRT and at the Cell & Gene Therapy Manufacturing & Commercialization Europe conference in Dublin, December 4-7.

As a leader in the CGT field, NIBRT’s Principal Investigator Jonathan Bones will present cutting-edge research on “Characterisation of AAV on Multiple Levels Using Liquid Phase Separations Coupled to Mass Spectrometry.”

His session will demonstrate advanced analytical techniques for characterizing adeno-associated viral vectors, providing practical solutions to pressing AAV gene therapy manufacturing challenges.

Join 400+ global CGT leaders and innovators in Cell & Gene Therapy at this premier European conference. Propelled by the latest strategies in process development, analytics, and market access – this is your opportunity to elevate your CGT programs towards commercial success.

As an Advanced Therapeutics Ireland affiliate, enjoy 10% off passes with code “ATMP10” on top of early bird rates. Startups can take advantage of affordable rates too – more than 50% off.

Register for the event